313747
Differential Rates in Acute HIV Infection Diagnosis in Men who Have Sex with Men at a Community-based Organization in Los Angeles, California
Methods: Data were analyzed for all HIV positive diagnoses given to MSM at the L.A. Gay & Lesbian Center between January 2011 and January 2014 (n=618). Acute HIV infections were defined as a negative result for an HIV antibody test paired with a positive result for a HIV nucleic acid amplification test (NAAT). Acute HIV infections were compared to non-acute HIV infections in a multivariate logistic regression by race, age group and education level.
Results: The proportion of acute HIV diagnoses was 16.3% in White MSM but only 4.6% in African-American MSM. A multivariate logistic regression showed that African-American MSM had 74% lower odds of acute HIV infection diagnosis when compared to White MSM (p=0.04, OR: 0.26; CI: 0.11-0.66), controlling for age group and education level.
Discussion: African-American MSM in this study accounted for a significantly lower proportion of acute HIV infections than other racial groups. This study demonstrates that African-American MSM have lower rates of early HIV detection, potentially contributing to increased HIV transmission. NAAT testing should be more actively promoted in the African-American MSM community of Los Angeles as a tool for early HIV detection.
Learning Areas:
Public health or related public policyLearning Objectives:
Identify racial disparities in early/acute identification of HIV
Describe methods for early detection of HIV in the most high-risk populations
Keyword(s): HIV Risk Behavior, Minority Health
Qualified on the content I am responsible for because: I am PhD student in Public Health at the University of California, Los Angeles. In addition, I have worked for the past three years as the epidemiologist for the L.A. Gay & Lesbian Center with a specialization in the epidemiology of sexually transmitted infections including HIV.
Any relevant financial relationships? No
I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.